In studying the response to IL-6 treatment in the context of insulin resistance and type 2 diabetes, Jiang et al. found 120 ng/ml IL-6 similarly increased AMPK signalling in human primary muscle cells isolated from the vastus lateralis of healthy volunteers and individuals with type 2 diabetes (Jiang et al., 2013). Here, IL6 is linked to type 2 diabetes mellitus.